New Q&As on Chapter 4 and 5 of the EU-GDP Guidelines
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
On the GDP Association Website a section was set up a while ago dealing with frequently asked questions (FAQs). Now a set of new FAQs has been published on Chapter 4 (Documentation) and Chapter 5 (Operations).
For example, the following questions are discussed:
- Who authors documents? Who needs to approve them?
- In which language should documents be written?
- Is it allowed to print procedures from an electronic system?
- How can I check if a supplier has an appropriate legal authorisation?
- Besides temperature, are there other environmental factors which might harm medicinal products?
- Why do I need to qualify customers?
Answers to these and other questions are provided in the new FAQs on GDP.
Related GMP News
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations
11.08.2026Call for Presentations: GDP Forum 2027 in Berlin
11.08.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 5
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information


